A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
Public ClinicalTrials.gov record NCT02150499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting
Study identification
- NCT ID
- NCT02150499
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Interventions
- levalbuterol tartrate HFA inhalation aerosol Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 48 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2014
- Primary completion
- Nov 30, 2014
- Completion
- Nov 30, 2014
- Last update posted
- Apr 7, 2016
2014
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Score Physician Alliance, LLC | St. Petersburg | Florida | 33710 | — |
| Northern Illinios Research Associates | DeKalb | Illinois | 60115 | — |
| Northern Illinois Associates | DeKalb | Illinois | 60115 | — |
| Michael W. Simon, MD, PSC | Nicholasville | Kentucky | 40356 | — |
| Willis-Knighton Physician Network / Portico Pediatrics | Shreveport | Louisiana | 71105 | — |
| Mid Michigan Sleep Center | Grand Blanc | Michigan | 48439 | — |
| Craig Spiegel, MD | Bridgeton | Missouri | 63044 | — |
| St. Peter's University Hospital | New Brunswick | New Jersey | 08901 | — |
| Capital Pediatrics & Adolescent Center PLLC | Raleigh | North Carolina | 27609 | — |
| Capitol Pediatric & Adolescent Center PLLC | Raleigh | North Carolina | 27609 | — |
| Dayton Clinical Research | Dayton | Ohio | 45406 | — |
| Charleston Allergy & Asthma Research | Summerville | South Carolina | 29485 | — |
| Holston Medical Group | Kingsport | Tennessee | 37660 | — |
| TTS Research | Boerne | Texas | 78006 | — |
| Allergy Asthma Research Institute | Waco | Texas | 76712 | — |
| PI-Coor Clinical Research | Burke | Virginia | 22015 | — |
| Advanced Pediatrics | Vienna | Virginia | 22180 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02150499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2016 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02150499 live on ClinicalTrials.gov.